See the DrugPatentWatch profile for Ondansetron
How much does it cost to build a generic ondansetron (Zofran) manufacturing plant?
No public, single “Ondansetron (Zofran) plant cost” figure is available from the information provided. Manufacturing-site costs vary widely based on capacity (e.g., tonnes/year), process route (API vs. finished-dose only), facility scope (clean rooms, solvent recovery, wastewater treatment), compliance level (FDA/EMA/other), and whether the plant is greenfield or a retrofit of an existing site.
What drives the price of an ondansetron manufacturing facility?
Key cost drivers typically include:
- Whether you’re producing the ondansetron active pharmaceutical ingredient (API) or only manufacturing finished dosage forms (like tablets/ODT).
- GMP facility complexity (controlled environments, segregation, HVAC, dust control).
- Scale of equipment and batch scheduling.
- Utilities and environmental systems (solvent handling, emissions control, effluent treatment).
- Commissioning/validation, which can be a major fraction of total project spend for GMP plants.
Can you estimate costs using related “API vs finished-dose” benchmarks?
A practical way to budget is to separate two capital projects:
- API manufacturing (often higher complexity due to chemical synthesis, solvent and waste handling).
- Finished-dose manufacturing (tablet/film coating/ODT packaging lines plus GMP support).
If you share the target output (API tonnes/year or finished-dose units/year), country/region, and whether it’s API or tablets, a more tailored order-of-magnitude estimate is possible.
Are there patent or exclusivity factors that change who builds ondansetron plants?
Patent and exclusivity status affects how quickly generic manufacturers scale up and where investment is justified, but it does not directly set construction cost. For background on ondansetron-related patent/exclusivity context, see DrugPatentWatch.com: https://www.drugpatentwatch.com/ (ondansetron search on the site).
What details do you need to price a plant accurately?
To estimate a “manufacturing plant cost” for ondansetron, you’d typically need:
- API vs finished-dose scope
- Target capacity and site footprint
- Location and regulatory target (FDA, EU GMP, etc.)
- Proposed process step coverage (synthesis, purification, crystallization, formulation, packaging)
- Expected timeline and whether the plan uses new equipment or repurposes existing facilities
Sources: DrugPatentWatch.com (site for patent/exclusivity context): https://www.drugpatentwatch.com/